| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: DNA Viruses |
Department of Medical Microbiology1 and Section of Infection and Immunity2, University of Wales College of Medicine, Tenovus Building, Heath Park, Cardiff CF14 4XN, UK
Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3US, UK3
Author for correspondence: Gavin Wilkinson. Fax +44 29 20745003. e-mail WilkinsonGW1{at}cf.ac.uk
Herpesvirus immediate-early (IE) gene products play key roles in establishing productive infections, regulating reactivation from latency and evading immune recognition. Analyses of HHV-6 IE gene expression have revealed that the IE1 gene of the HHV-6A and HHV-6B variants exhibits a higher degree of sequence variation than other regions of the genome and no obvious similarity to its positional analogue in HCMV. We have analysed expression of the HHV-6 U1102 (HHV-6A) and Z29 (HHV-6B) IE1 gene products using transient expression vectors, stable cell lines and in the context of lytic virus infection. The IE1 transcripts from both variants demonstrate a similar pattern of splice usage within their translated regions. The HHV-6 IE1 proteins from both variants traffic to, and form a stable interaction with, PML-bodies (also known as ND10 or PODS). Remarkably, PML-bodies remained structurally intact and associated with the IE1 protein throughout lytic HHV-6 infection. Immunoprecipitation studies demonstrated that HHV-6 IE1 from both variants is covalently modified by conjugation to the small ubiquitin-like protein SUMO-1. Overexpression of SUMO-1 in cell lines resulted in substantially enhanced levels of IE1 expression; thus sumoylation may bestow stability to the protein. These results indicate that the HHV-6 IE1 protein interacts with PML-bodies yet, unlike other herpesviruses, HHV-6 appears to have no requirement or mechanism to induce PML-body dispersal during lytic replication.
This article has been cited by other articles:
|
|
 |
|
  E. Kofod-Olsen, K. Ross-Hansen, J. G. Mikkelsen, and P. Hollsberg Human herpesvirus 6B U19 protein is a PML-regulated transcriptional activator that localizes to nuclear foci in a PML-independent manner J. Gen. Virol., January 1, 2008; 89(1): 106 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tomoiu, A. Gravel, R. M. Tanguay, and L. Flamand Functional Interaction between Human Herpesvirus 6 Immediate-Early 2 Protein and Ubiquitin-Conjugating Enzyme 9 in the Absence of Sumoylation. J. Virol., October 1, 2006; 80(20): 10218 - 10228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kang, E. T. Kim, H.-R. Lee, J.-J. Park, Y. Y. Go, C. Y. Choi, and J.-H. Ahn Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein. J. Gen. Virol., August 1, 2006; 87(Pt 8): 2181 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takemoto, M. Koike, Y. Mori, S. Yonemoto, Y. Sasamoto, K. Kondo, Y. Uchiyama, and K. Yamanishi Human Herpesvirus 6 Open Reading Frame U14 Protein and Cellular p53 Interact with Each Other and Are Contained in the Virion J. Virol., October 15, 2005; 79(20): 13037 - 13046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gravel, V. Dion, N. Cloutier, J. Gosselin, and L. Flamand Characterization of human herpesvirus 6 variant B immediate-early 1 protein modifications by small ubiquitin-related modifiers J. Gen. Virol., May 1, 2004; 85(5): 1319 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mori, X. Yang, P. Akkapaiboon, T. Okuno, and K. Yamanishi Human Herpesvirus 6 Variant A Glycoprotein H-Glycoprotein L-Glycoprotein Q Complex Associates with Human CD46 J. Virol., April 15, 2003; 77(8): 4992 - 4999. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
